Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.

ABSTRACT:

Importance

Opioid use disorder (OUD) frequently begins in adolescence and young adulthood. Intervening early with pharmacotherapy is recommended by major professional organizations. No prior national studies have examined the extent to which adolescents and young adults (collectively termed youth) with OUD receive pharmacotherapy.

Objective

To identify time trends and disparities in receipt of buprenorphine and naltrexone among youth with OUD in the United States.

Design, setting, and participants

A retrospective cohort study was conducted using deidentified data from a national commercial insurance database. Enrollment and complete health insurance claims of 9.7 million youth, aged 13 to 25 years were analyzed, identifying individuals who received a diagnosis of OUD

SUBMITTER: Hadland SE 

PROVIDER: S-EPMC5649381 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature